M. Drijkoningen

2.9k total citations
56 papers, 1.6k citations indexed

About

M. Drijkoningen is a scholar working on Oncology, Cancer Research and Epidemiology. According to data from OpenAlex, M. Drijkoningen has authored 56 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 17 papers in Cancer Research and 11 papers in Epidemiology. Recurrent topics in M. Drijkoningen's work include Breast Cancer Treatment Studies (12 papers), HER2/EGFR in Cancer Research (11 papers) and Immunotherapy and Immune Responses (10 papers). M. Drijkoningen is often cited by papers focused on Breast Cancer Treatment Studies (12 papers), HER2/EGFR in Cancer Research (11 papers) and Immunotherapy and Immune Responses (10 papers). M. Drijkoningen collaborates with scholars based in Belgium, Netherlands and Israel. M. Drijkoningen's co-authors include Isabelle Vanden Bempt, Robert Paridaens, Christiane De Wolf‐Peeters, Erik Van Limbergen, Patrick Neven, Valeer Desmet, P. Ide, Roger Bouillon, Marie-Rose Christiaens and Ignace Vergote and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and Cancer Research.

In The Last Decade

M. Drijkoningen

56 papers receiving 1.6k citations

Peers

Countries citing papers authored by M. Drijkoningen

Since Specialization

Citations

This map shows the geographic impact of M. Drijkoningen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Drijkoningen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Drijkoningen more than expected).

Fields of papers citing papers by M. Drijkoningen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Drijkoningen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Drijkoningen. The network helps show where M. Drijkoningen may publish in the future.

Co-authorship network of co-authors of M. Drijkoningen

This figure shows the co-authorship network connecting the top 25 collaborators of M. Drijkoningen. A scholar is included among the top collaborators of M. Drijkoningen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Drijkoningen. M. Drijkoningen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	BELGIAN CONSENSUS GUIDELINES FOR FOLLOW-UP OF WOMEN WITH CERVICAL CYTOLOGICAL ABNORMALITIES 2009 ·Acta Clinica Belgica ·Claude Cuvelier, Johannes Bogers, C. Bourgain, (unknown), M. Drijkoningen, Christian Garbar, (unknown), (unknown), (unknown), Alain Verhest, Birgit Weynand, (unknown)	4
2	Triple negative breast cancer: a study from the point of view of basal CK5/6 and HER-1 2009 ·Journal of Clinical Pathology ·(unknown), P. Neven, M. Drijkoningen, V. Van Belle, Philippe Moerman, M-R Christiaens, Ann Smeets, Hans Wildiers, Isabelle Vanden Bempt	31
3	Quantity and quality of retrograde menstruation: a case control study 2009 ·Reproductive Biology and Endocrinology ·Attila Bokor, Sophie Debrock, M. Drijkoningen, Willy Goossens, Vilmos Fülöp, Thomas D’Hooghe	30
4	Adenomyoepitheliomatous lesions of the mammary glands in transgenic mice with targeted PLAG1 overexpression 2008 ·International Journal of Cancer ·Jeroen Declercq, Ivar Skaland, Frederik Van Dyck, Emiel A. M. Janssen, Jan P. Baak, M. Drijkoningen, Wim J.M. Van de Ven	14
5	Age interacts with the expression of steroid and HER-2 receptors in operable invasive breast cancer 2007 ·Breast Cancer Research and Treatment ·Patrick Neven, Ben Van Calster, (unknown), Sabine Van Huffel, V. Van Belle, Wouter Hendrickx, Julie Decock, Hans Wildiers, Robert Paridaens, Frédéric Amant, Karin Leunen, Patrick Berteloot, D. Timmerman, Erik Van Limbergen, Caroline Weltens, W. Van den Bogaert, Ann Smeets, Ignace Vergote, (unknown), M. Drijkoningen	12
6	Sentinel lymph node biopsy and non-sentinel node involvement in special type breast carcinomas with a good prognosis 2007 ·European Journal of Cancer ·Gábor Cserni, Simonetta Bianchi, Vania Vezzosi, Riccardo Arisio, Rita Bori, Johannes L. Peterse, Anna Sapino, M. Drijkoningen, Janina Kulka, Vincenzo Eusebi, Maria Pia Foschini, J P Bellocq, Cristi Marin, Sten Thorstenson, Isabel Amendoeira, Angelika Reiner‐Concin, Thomas Decker	11
7	Matrix Metalloproteinase Expression Patterns in Luminal A Type Breast Carcinomas 2007 ·Disease Markers ·Julie Decock, Wouter Hendrickx, M. Drijkoningen, Hans Wildiers, Patrick Neven, Ann Smeets, R. Paridaens	19
8	Comparative expressed sequence hybridization reveals differential gene expression in morphological breast cancer subtypes 2006 ·The Journal of Pathology ·Isabelle Vanden Bempt, Vera Vanhentenrijk, M. Drijkoningen, Christiane De Wolf‐Peeters	11
9	Prediction of recurrence after treatment for high‐grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation 2006 ·BJOG An International Journal of Obstetrics & Gynaecology ·(unknown), (unknown), Gilbert Donders, Marc Arbyn, Johan Van Eldere, M. Drijkoningen, (unknown)	112
10	The influence of body composition and hormone replacement therapy (HRT) on progesterone receptor (PR) expression in postmenopausal women with an oestrogen receptor (ER)-positive breast cancer 2006 ·International Journal of Gynecological Cancer ·Tim Van Mieghem, Karin Leunen, Nathalie Pochet, (unknown), Bart De Moor, Frank De Smet, Frédéric Amant, Patrick Berteloot, (unknown), (unknown), M. Drijkoningen, Erik Van Limbergen, Ann Smeets, Hans Wildiers, Robert Paridaens, M-R Christiaens, Ignace Vergote, Patrick Neven	3
11	Cytopathology in Belgium 2005 ·Cytopathology ·M. Drijkoningen, Johannes Bogers, C. Bourgain, Claude Cuvelier, Philippe Delvenne, (unknown), (unknown), (unknown), Bart Van Damme, Liesbet Van Eycken, Alain Verhest, Birgit Weynand	2
12	Hormone receptors do not predict the HER2/neu status in all age groups of women with an operable breast cancer 2005 ·Annals of Oncology ·Huei-Jean Huang, Patrick Neven, M. Drijkoningen, Robert Paridaens, Hans Wildiers, Erik Van Limbergen, Patrick Berteloot, Frédéric Amant, Ignace Vergote, M-R Christiaens	49
13	Association between HER-2/neu and the progesterone receptor in oestrogen-dependent breast cancer is age-related 2005 ·Breast Cancer Research and Treatment ·Huei‐Jean Huang, Patrick Neven, M. Drijkoningen, Robert Paridaens, Hans Wildiers, Erik Van Limbergen, Patrick Berteloot, Frédéric Amant, (unknown), Ignace Vergote	49
14	Use of Liquid-Based Cytology in Serous Fluids 2004 ·Acta Cytologica ·(unknown), Ruth Achten, M. Drijkoningen	31
15	Effect of TNP-470 (AGM-1470) on the Growth of Rat Rhabdomyosarcoma Tumors of Different Sizes 2001 ·Cancer Investigation ·Willy Landuyt, Jan Theys, Sandra Nuyts, M. Drijkoningen, Jack Fowler, (unknown), Sandra Liekens, Johan Neyts, Ernst de Bruijn, Jozef Anné, Philippe Lambin	2
16	Quantity and Quality of Retrograde Menstruation: Red Blood Cells, Inflammation and Peritoneal Cells 2000 ·Fertility and Sterility ·Sophie Debrock, M. Drijkoningen, Willy Goossens, Christel Meuleman, (unknown), Thomas D’Hooghe	1
17	Tobacco Smoking Impairs the Local Immunosurveillance in the Uterine Cervix 1995 ·Gynecologic and Obstetric Investigation ·Willy Poppe, P. Ide, M. Drijkoningen, Joseph M. Lauweryns, André Van Assche	79
18	The source-skin distance measuring bridge: A method to avoid radiation teleangiectasia in the skin after interstitial therapy for breast cancer 1990 ·International Journal of Radiation OncologyBiologyPhysics ·Erik Van Limbergen, E. Briot, M. Drijkoningen	28
19	Epidermal Langerhans cells, dermal dendritic cells, and keratinocytes in viral lesions of skin and mucous membranes: an immunohistochemical study 1988 ·Archives of Dermatological Research ·M. Drijkoningen, Chris De Wolf‐Peeters, H. Degreef, Valeer Desmet	36
20	Drug-induced skin reactions and acute cutaneous graft-versus-host reaction: a comparative immunohistochemical study 1988 ·Annals of Hematology ·M. Drijkoningen, C. De Wolf‐Peeters, Guido Tricot, H. Degreef, Valeer Desmet	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact